http://asiapharmaceutics.info/index.php/ajp/issue/feedAsian Journal of Pharmaceutics (AJP)2024-10-24T07:14:22+00:00M.A. Naidueditor@asiapharmaceutics.infoOpen Journal Systems<p style="text-align: justify;"><strong>Asian Journal of Pharmaceutics</strong> is an international Referred and Peer Reviewed Online and print Journal with E-ISSN: <strong>1998-409X </strong>and P-ISSN: <strong>0973-8398 </strong>published by<strong> B R Nahata Smriti Sansthan </strong>for the enhancement of research and extension in Pharmaceutics. AJP is an open access online Journal, that publishes full-length papers, reviews and short communications exploring and to promote diverse and integrated areas of Pharmaceutics and Pharmaceutical Technology, Formulation Design and Development, Drug Discovery and Development Interface, Manufacturing Science and Engineering, Pharmacokinetics, Pharmacodynamics, and Drug Metabolism, Clinical Pharmacology, General Medicine and Translational Research, Physical Pharmacy and Biopharmaceutics, Novel Drug delivery system, Biotechnology & Microbiological evaluations, Regulatory Sciences. AJP is steered by a distinguished Board of Editors. To maintain a high-quality journal, manuscripts that appear in the AJP Articles section have been subjected to a rigorous review process.</p> <p><strong><u>JOURNAL PARTICULARS</u></strong></p> <table> <tbody> <tr> <td width="281"> <p>Title</p> </td> <td width="517"> <p>Asian Journal of Pharmaceutics</p> </td> </tr> <tr> <td width="281"> <p>Frequency</p> </td> <td width="517"> <p>Quarterly</p> </td> </tr> <tr> <td width="281"> <p>E- ISSN</p> </td> <td width="517"> <p><strong>1998-409X</strong></p> </td> </tr> <tr> <td width="281"> <p>P-ISSN</p> </td> <td width="517"> <p><strong>0973-8398</strong></p> </td> </tr> <tr> <td width="281"> <p>DOI</p> </td> <td width="517"> <p><strong>https://doi.org/10.22377/ajp.v10i04</strong></p> </td> </tr> <tr> <td width="281"> <p>Publisher</p> </td> <td width="517"> <p><strong>Mr. Narendra Nahata</strong>, B.R. Nahata College of Pharmacy, Mhow-Neemuch Road, Mandsaur-458001, Madhya Pradesh</p> </td> </tr> <tr> <td width="281"> <p>Chief Editor</p> </td> <td width="517"> <p>Dr. M.A. Naidu</p> </td> </tr> <tr> <td width="281"> <p>Starting Year</p> </td> <td width="517"> <p>2007</p> </td> </tr> <tr> <td width="281"> <p>Subject</p> </td> <td width="517"> <p>Pharmacy subjects</p> </td> </tr> <tr> <td width="281"> <p>Language</p> </td> <td width="517"> <p>English Language</p> </td> </tr> <tr> <td width="281"> <p>Publication Format</p> </td> <td width="517"> <p>Online and Print [Both]</p> </td> </tr> <tr> <td width="281"> <p>Email Id</p> </td> <td width="517"> <p><a href="mailto:editor@asiapharmaceutics.info">editor@asiapharmaceutics.info</a>,editor@brnsspublicationhub.org</p> </td> </tr> <tr> <td width="281"> <p>Mobile No.</p> </td> <td width="517"> <p>+91-7049737901</p> </td> </tr> <tr> <td width="281"> <p>Website</p> </td> <td width="517"> <p>www.asiapharmaceutics.info</p> </td> </tr> <tr> <td width="281"> <p>Address</p> </td> <td width="517"> <p>B.R. Nahata Smriti Sansthan, BRNSS PUBLICATION HUB, B.R. Nahata College of Pharmacy, Mhow-Neemuch Road, Mandsaur-458001, Madhya Pradesh</p> </td> </tr> </tbody> </table> <p> </p>http://asiapharmaceutics.info/index.php/ajp/article/view/5655Ultrasound Diagnosis of Cholecystitis and Cholelithiasis: A Study of Various Types and Complications for Better Management2024-10-24T07:14:22+00:00Taalaibek Bekov, Jumabek Mamasaliev, Ertegin Baigashkaev, Tugolbai Tagaevbekovtaalaibek@gmail.com<p>Introduction: Ultrasound examination plays a crucial role in diagnosing cholecystitis and cholelithiasis, but its<br>reliability in predicting inflammation severity and distinguishing between acute and chronic cholecystitis remains<br>contested. This study aimed to provide ultrasound examination of various types of cholecystitis and cholelithiasis.<br>Materials and Methods: A total of 650 subjects, including 48 healthy controls and 602 patients who underwent<br>surgery for acute, chronic, destructive cholecystitis, or cholelithiasis, were examined using a Siemens scanner.<br>Ultrasonography parameters assessed blood flow in the branches and veins of the cystic artery using color Doppler<br>scanning and pulsed-wave Doppler. Quantitative blood flow velocity indicators and angle-independent total<br>peripheral resistance indices were examined. Results: Gallbladder length and area were significantly increased<br>in acute, phlegmonous, and gangrenous inflammation compared to controls. Wall thickness exceeded 4–5 mm<br>in acute and phlegmonous-gangrenous inflammation. Maximum systolic blood flow velocity in the cystic artery<br>more than doubled in acute, phlegmonous, and gangrenous inflammation, while minimum systolic velocity<br>showed no significant changes. Total peripheral resistance indices increased in chronic, phlegmonous, and<br>gangrenous inflammation but remained within control values in acute inflammation. The control group showed no<br>significant differences in ultrasonographic indicators across all age groups. Conclusion: These findings highlight<br>the importance of comprehensive clinical assessment alongside ultrasound imaging for accurate diagnosis and<br>management of cholecystitis and cholelithiasis.</p>2024-10-24T00:00:00+00:00Copyright (c) 2024 Taalaibek Bekovhttp://asiapharmaceutics.info/index.php/ajp/article/view/5645Synthesize and Characterize the Lipoid S-75 Conjugated Chitosan-Based Micelles for Improving Biopharmaceutical Parameters of Resveratrol2024-10-24T06:38:58+00:00Mrunal Deshmukhmrunal.pharmacy@dmiher.edu.in<p>The anticancer activity of resveratrol is well known. But because of its limited water solubility and low<br>bioavailability, resveratrol (RES) is a BCS class II medication with research potential. The current work creates<br>a new copolymer from Lipoid S-75 and chitosan and tests the RES-loaded micelles it produces for varied<br>delivery properties. In addition to efficiently loading the drug, the nanometric micellar carriers also regulated<br>the rate of RES release. The discoveries using a novel polymer-based carrier show promise for improved<br>medication delivery in the future. Aim: The aim of the study was to synthesize and characterize the lipoid S-75<br>conjugated chitosan-based micelles for improving biopharmaceutical parameters of resveratrol. Methods: The<br>preparation and characterization of a copolymer of CS and lipoid S-75 were done by using S-75 100 mg and<br>DCC 700 mg which is followed by preparation and characterization of CS-lipoid S-75-conjugated resveratrol<br>micelles. And evaluation of the formulation done by the parameters such as particle size, polydispersity<br>index zeta potential, % encapsulation efficiency and drug loading, drug loading capacity, and differential<br>scanning calorimetry. Results: In the present study, development of polymeric micelles using the flavonoid<br>in multifaceted applications, entailing therapy, diagnostics, in-suit imaging, and on-demand drug delivery,<br>resveratrol, polymers such as chitosan, and lipoid S-75 show significant potential. The fundamental formation<br>mechanisms are then analyzed, focusing on the inherent physicochemical qualities like solubility and<br>bioavailability that control the drug release. Conclusion: The development of resveratrol-loaded chitosanbased<br>S-75 micelles demonstrates considerable potential for multifaceted biomedical applications, including<br>therapy, diagnostics, in-situ imaging, and on-demand drug delivery. The combination of resveratrol, chitosan,<br>and lipoid S-75 results in a polymeric micellar system with enhanced solubility and bioavailability, addressing<br>the challenges associated with the poor aqueous solubility and rapid metabolism of resveratrol. The analysis<br>of the micelle formation mechanisms highlights the crucial role of the inherent physicochemical properties<br>in controlling drug release. This innovative micellar platform offers promising avenues for optimizing the<br>therapeutic delivery of resveratrol and broadening its application scope in pharmaceutical and biomedical<br>fields.</p>2024-09-15T00:00:00+00:00Copyright (c) 2024 Mrunal Deshmukhhttp://asiapharmaceutics.info/index.php/ajp/article/view/5646Development and Validation for Determination of Apremilast in Bulk and in Tablets by UV Spectrophotometer2024-10-24T06:41:49+00:00Narender Bogguladrnarenderboggula@gmail.com<p>Background: Pharmaceutical analysis plays a key role in the quality assurance and quality control of bulk drugs.<br>A documented validation program offers a high level of confidence that an operation or facility will consistently<br>deliver a product that satisfies a set standard. A premilast is an aphosphodiesterase-4 inhibitor used in the<br>treatment of psoriasis. Objective: The main objective is to develop a simple, rapid, accurate, and economical<br>spectrophotometric method for the determination of apremilast in bulk and its tablet dosage form as per ICH<br>guidelines. Materials and Method: The estimation was carried out using HPLC-grade acetonitrile as a solvent<br>and quantitation was achieved using a double-beam UV spectrophotometer at 230 nm. The present method was<br>suitable for its intended purpose as prescribed in ICH Q2 guidelines. The analytical method was validated to<br>determine the linearity, precision, accuracy, robustness, ruggedness, LOD, and LOQ of the method. Results: The<br>λmax of apremilast in acetonitrile was found to be 230 nm. The drug has a correlation coefficient (r2) value of<br>0.999 and exhibits linearity in the concentration range of 2–10 μg/mL. The proposed method was applied to<br>pharmaceutical formulation and % the amount of drug estimated 99% was found in good agreement with the label<br>claim. The repeatability, intraday, and interday changes of accuracy were examined. The approach is considered<br>exact if the percentage RSD value is <2. Conclusion: The above method was a rapid and cost-effective quality<br>control tool for routine analysis of apremilast in bulk and in pharmaceutical dosage form. The method can be useful<br>for the day-to-day routine analysis in the quality control departments of bulk and pharmaceutical formulations<br>industries.</p>2024-09-15T00:00:00+00:00Copyright (c) 2024 Narender Boggulahttp://asiapharmaceutics.info/index.php/ajp/article/view/5648Analytical HPLC Method for Determination of Miconazole Nitrate and Eugenol in Formulated Emulgel2024-10-24T06:44:36+00:00Aarti S. Zanwaraarti.zanwar@gmail.com<p>Aim: Conventional antifungal medications face challenges, such as recurrence of infection, medication resistance,<br>and drug-related toxicity. Biofilm-associated cells exhibit resistance due to drug-efflux pumps and metabolic<br>conditions. A new formulation containing miconazole nitrate (MIZ) (antifungal drug) and eugenol (EUL) (antibiofilm<br>agent) increases the effectiveness of antifungal activity. This necessitates a new high-pressure liquid<br>chromatography (HPLC) method to develop for quality control analysis. Materials and Methods: The proportion<br>of solvent (acetonitrile: methanol:ammonium acetate buffer, pH 6.5) in the ratio of 25:55:20 v/v/v resolved the<br>cited drugs on the C8 column at 238 nm by the HPLC method. The developed method was validated as per<br>the International Council for Harmonisation Q2 guideline for different parameters. Result and Discussion: The<br>linearity and range for MIZ (50–250 μg/mL) and EUL (26.5–132.5 μg/mL) solution were performed by the<br>mentioned HPLC method. The interferences of the excipients, MIZ and EUL, were negligible, as the recovery<br>percentage ranged from 98.867% to 101.482%. The quantified drug content was determined to be 98.450 ± 1.303<br>for MIZ and 97.467 ± 1.250 for EUL by the developed and validated HPLC method. Conclusion: The proposed<br>research was appropriate for the examination of MIZ and EUL content in the formulated emulgel by the developed<br>HPLC method.</p>2024-09-15T00:00:00+00:00Copyright (c) 2024 Aarti S. Zanwarhttp://asiapharmaceutics.info/index.php/ajp/article/view/5624Development, Optimization, and In vitro Evaluation of Ethosomal Gel of Dalbergia sissoo Leaves Extract2024-10-24T05:44:01+00:00Vanshita Singhsinghvanshita1997@gmail.com<p>Aim: The present study aimed to develop an ethosomal gel loaded with Dalbergia sissoo leaves extract for<br>transdermal application. Materials and Methods: D. sissoo extract was subjected to phytochemical analysis,<br>flavonoid content, total phenolic content, and Fourier-Transform Infrared Spectroscopy analysis. The ethosomes<br>containing D. sissoo extract were formulated and characterized based on morphology, particle size, surface charge,<br>and encapsulation efficiency. Subsequently, the optimized ethosomes were incorporated into Carbopol gel and<br>then evaluated for organoleptic properties, pH, viscosity, and skin permeation. Results and Discussion: Dalbergia<br>extract incorporated in the ethosomes showed spherical shape, vesicle size (143 nm), −14.9 mV surface charge,<br>and good entrapment efficiency (84.4%). The optimized formulation was further incorporated into Carbopol gel<br>and showed optimal pH (6.2), good spreadability, high release percentage (85.92%), as well as stability over<br>60 days. Conclusion: The findings revealed that the ethosomal gel loaded with D. sissoo leaves extract was found<br>to be a potential strategy for effective delivery.</p>2024-09-15T00:00:00+00:00Copyright (c) 2024 Vanshita Singh Singhhttp://asiapharmaceutics.info/index.php/ajp/article/view/5627Development and Validation of Reversed-phase High-performance Liquid Chromatography Method for Simultaneous Estimation of Desonide and Curcumin in Topical Dosage Form2024-10-24T05:52:52+00:00Rahul L. Wamanrahulwaman044@gmail.com<p>A reversed-phase high-performance liquid chromatography (RP-HPLC) method was developed and validated to<br>simultaneously determine curcumin and desonide in both bulk and pharmaceutical dosage forms. This method is<br>characterized by its simplicity, sensitivity, speed, specificity, precision, and accuracy. The mobile phase consisted<br>of a mixture with a ratio of 65:35 v/v, and the flow rate was maintained at 0.8 mL/min. Chromatographic separation<br>was achieved using a C18 column (250 × 4.6 mm – 5 μm p.s), with ultraviolet detection performed at 240 nm.<br>An injection volume of 20 μL was used. The retention times for desonide and curcumin were 3.45 and 7.51 min,<br>respectively, resulting in distinct and well-defined chromatographic peaks. The respective percentage recoveries<br>were 99.56% and 99.87%. The suggested approach demonstrated strong linearity, accuracy, and precision, and<br>it was effectively used to determine the medicines in pharmaceutical dosage forms. The current approach was<br>created and successfully used to ascertain the quantities of curcumin and desonide in a combined formulation after<br>it was statistically validated in compliance with the ICH recommendations.</p>2024-09-15T00:00:00+00:00Copyright (c) 2024 Rahul L. Wamanhttp://asiapharmaceutics.info/index.php/ajp/article/view/5630Investigating the Impact of Chronic Diseases and Disability on Quality of Life in Saudi Arabian Patients2024-10-24T05:58:36+00:00Syed Mohammed Basheeruddin Asdaqsasdaq@gmail.com<p>Background and Objective: With greater life expectancy comes an increased risk of chronic diseases, which can<br>lead to disability. This study aimed to investigate the relationship between chronic diseases and the development<br>of disability, as well as their impact on quality of life (QoL). Methods: From March to May of 2024, a crosssectional<br>survey was conducted in Riyadh, Saudi Arabia. Participants in the study were approached in a range of<br>locations, such as disability centres, hospitals, health clinics, community gatherings, charity events, and health<br>camps. The participants were given link to online questionnaires supplied via Google Forms. With SPSS-IBM<br>2023, the descriptive analysis was carried out. A significance level of P < 0.05 was applied to all comparisons.<br>A binary regression analysis was done to determine factors that influence the QoL of the participants, while a<br>multinomial regression analysis was carried out to explore factors that triggered the difficulty due to disability.<br>Results: Of the 394 study participants, 70.8% were female and represented a range of age categories. Thirty-seven<br>percent of the participants held a degree or higher education, and more than half of them—54 percent—were<br>married. Compared to individuals without a disability, people with mild or severe disabilities are 2.355 times<br>more likely to report a decline in QoL. There is a considerable chance that participants’ quality of life will decline<br>when the number of chronic diseases rises from one to two or more. The quality of life (QoL) significantly<br>improved 1.943 times among married individuals compared to those who lived alone. Growing older is linked to<br>notable shifts in attaining a high quality of life. In general, women suffered from higher levels of disability than<br>men did; people with good quality of life and physical activity were less likely to have higher disability indices.<br>Conclusion: According to the study’s findings, the number of chronic illnesses and the onset of difficulty are<br>related, and both considerably lower quality of life. Stabilizing quality of life, preventing disability, and managing<br>chronic diseases all require effective processes involving patients, family members, and healthcare providers.</p>2024-09-15T00:00:00+00:00Copyright (c) 2024 Syed Mohammed Basheeruddin Asdaqhttp://asiapharmaceutics.info/index.php/ajp/article/view/5632Integrating Quality by Design Principles for Elevating Bioavailability of Candesartan Cilexetil in Fast-dissolving Tablets2024-10-24T06:01:42+00:00Chandra Shekar Thallurichandu6716@gmail.com<p>Aim: The present research was aimed to increase the bioavailability of Candesartan cilexetil by integrating<br>efficient super disintegrating agents applying the principles of quality by design. Materials and Methods:<br>This study optimized fast dissolving tablets containing Candesartan cilexetil by integrating efficient super<br>disintegrating agents (Isabgol husk, Potato starch, F melt C) through a direct compression method. Utilizing Design<br>of Expert version 13.0 with a response surface methodology, formulations (CC1-CC15) were systematically<br>developed. The influence of super disintegrates on key parameters - disintegration time (Y1), drug release at<br>15 min (Y2), and drug release at 30 minutes (Y3) - was extensively studied to enhance Candesartan cilexetil’s<br>dissolution properties. Results and Discussion: Comprehensive evaluation of pre- and post-compressional<br>factors, coupled with robust in-vitro dissolution analysis, highlighted formulation CC12’s excellence, featuring<br>rapid disintegration and maximal drug release within specified timeframes. Utilizing the DD solver guided by<br>regression coefficients (r2), Akaike Information Criterion (AIC), and model selection criteria (MSC), kinetics<br>and release mechanisms were elucidated. CC12 exhibited a fickian diffusion mechanism, substantiating its<br>robust drug release profile. Additionally, shelf-life evaluation as per ICH guidelines and a comparative analysis<br>employing the similarity factor (f2) with Atacand were conducted. Stability studies, assessed via ANOVA,<br>indicated insignificant differences (P > 0.05) during storage. In summary, this research optimally enhanced<br>Candesartan cilexetil’s dissolution via proficiently formulated fast dissolving tablets. The strategic integration<br>of super disintegrating agents, driven by Design of Expert version 13.0, yielded CC12 as an optimal candidate<br>with rapid disintegration and superior drug release. Elucidation of release kinetics and mechanisms further<br>fortified performance assessment. Thorough stability and similarity evaluations underscored the potential of this<br>optimized formulation for improved therapeutic outcomes. Conclusion: Fast dissolving tablets of C and esartan<br>cilexetil were developed by optimizing selected independent variables to improve the dissolution profile. The<br>presence of soluble polymers like Isabgol husk, potato starch and F melt C, acting as super disintegrants, played<br>a significant role in enhancing solubility.</p>2024-09-15T00:00:00+00:00Copyright (c) 2024 Chandra Shekar Thallurihttp://asiapharmaceutics.info/index.php/ajp/article/view/5634Prevalence of Cataract and Risk Factors in Al-Kharj, Saudi Arabia2024-10-24T06:06:17+00:00Ali Hassan A. Ali alihassan3750@yahoo.com<p>Introduction: Cataracts are a leading cause of blindness, predominantly affecting the elderly. This study aims to<br>estimate the prevalence of cataracts in Al-Kharj, Saudi Arabia, and identify associated risk factors and demographic<br>characteristics. Method: The study is a cross-sectional survey conducted for patients over 18 years old. The<br>patients’ demographics and medical history, including cataract diagnosis and risk factors, were collected and<br>analyzed using Statistical Package for the Social Sciences. Statistical tests included the Chi-square for categorical<br>variables and the t-test for continuous variables, with significance set at P < 0.05. Results: The study sample<br>consisted of 100 participants, with a female majority (59%) and a significant proportion of individuals over<br>67 years old (37%). Nuclear cataracts were the most common (80%), followed by cortical (36%) and posterior<br>subcapsular (PSC) cataracts (27%). Significant associations were found between diabetes and PSC cataracts<br>(P = 0.027), and between age and cataract grade (P < 0.001). Smoking and hypertension also showed significant<br>correlations with cataract types. Conclusion: Age, diabetes, hypertension, and smoking are significant risk factors<br>for cataracts in Al-Kharj. Nuclear cataracts are the most prevalent, especially in individuals over 67 years old. The<br>associations between cataracts (types and grades) and risk factors such as diabetes, smoking, and hypertension<br>should be considered. Addressing risk factors could reduce cataract-related visual impairment.</p>2024-09-15T00:00:00+00:00Copyright (c) 2024 EditorAli Hassan A. Alihttp://asiapharmaceutics.info/index.php/ajp/article/view/5640Molecular Docking Studies of Substituted Aromatic N-(3-chloro-4-fluorophenyl)-1- phenylmethanimine Derivatives against Monoamine Oxidase-B as Potential Anti-parkinsonian Agents2024-10-24T06:22:01+00:00Vijaya Kishore Kanakarajudrvijayakishore@gmail.com<p>Introduction: In recent times, Parkinson’s disease has been considered a major problem in most of the men than<br>women. The monoamine oxidase-B (MAO-B) inhibitors show anti-Parkinsonian activity. This study describes a range<br>of substituted aromatic N-(3-chloro-4-fluorophenyl)-1-phenylmethanimine derivatives that have been designed and<br>docked against the MAO-B enzyme to evaluate their potential anti-Parkinson’s agents. Comparison was made between<br>the ligands and common MAO-B inhibitors such as selegiline, rasagiline, and safinamide. Materials and Methods: First,<br>with the help of Chemsketch software, the ligands were drawn and saved in.mol format, and they were converted<br>to .pdb format using Avogadro software. iGEMDOCK software was used to perform molecular docking studies and<br>docked compounds were visualized through BIOVIA Discovery Studio Visualizer. Results and Discussion: Most<br>of the substances were found to have enhanced MAO-B enzyme binding affinities. The majority of the ligands have<br>demonstrated greater binding energies when compared with the standard MAO-B inhibitors, such as safinamide (−102.64<br>K.cal/mol), selegiline (−74.38 K.cal/mol), and rasagiline (−72.76 K.cal/mol). Compounds C23 (−120.20 K.cal/mol)<br>and C33 (−116.97 K.cal/mol) were found to have superior binding energies compared to the standard MAO-B inhibitors<br>and so were chosen for visualization. Conclusion: Derivatives of substituted aromatic N-(3-chloro-4-fluorophenyl)-1-<br>phenylmethanimine showed a higher binding affinity toward the MAO-B enzyme than standard inhibitors, suggesting<br>that they might be considered for the treatment of Parkinson’s disorder.</p>2024-10-24T00:00:00+00:00Copyright (c) 2024 Vijaya Kishore Kanakarajuhttp://asiapharmaceutics.info/index.php/ajp/article/view/5637Liquid Chromatography–Mass Spectrometry Study Focusing on Neuroprotective Effect of Compounds Obtained from Bacopa monnieri Juice2024-10-24T06:14:14+00:00K. Ramachandra Reddykrcreddy@bhu.ac.in<p>Introduction: According to Ayurvedic literature, Brahmi is highly recommended for the management of<br>psychiatric problems since it acts on the brain. In traditional Ayurvedic medicine, Brahmi, a herb is recommended<br>for the management of various psychological disorders such as Alakshmi (inauspicious condition), Unmada<br>(insanity), and Apasmara (epilepsy). Drug quality is a basic necessity in this day and age, and analytical testing<br>can help combat impurities or subpar pharmaceuticals. Materials and Methods: Compound analysis of Brahmi<br>Juice ( Swarasa) using liquid chromatographic mass spectrometry (LC-MS). Results: LC-MS analysis shows<br>major compound such as L-Phenylalanine, Phenylacetylene, DL-Arginine, Azelaic acid, Erucamide, D-(+)-<br>Pyroglutamic acid, L-Glutamic acid, Valine, Choline, L-Isoleucine, DL-Tryptophan, L-(-)-Methionine, and<br>Beta-Ionone which play a significant role in neuroprotection. Conclusion: The study showed the presence of<br>compounds rich in neurotransmitters which also act as neurotonics having their specific neuroprotective effect<br>in conditions such as Alzheimer’s Disease, Parkinsonism, and Dementia. By employing a wide array of testing<br>procedures, manufacturers are able to ensure compliance with regulatory requirements and supply consumers with<br>a better product that effectively delivers Brahmi’s therapeutic benefits.</p>2024-10-24T00:00:00+00:00Copyright (c) 2024 K. Ramachandra Reddyhttp://asiapharmaceutics.info/index.php/ajp/article/view/5642Across-Sectional Observational Study on Drug Utilization and Prescribing Patterns of Antibiotics in Lower Respiratory Tract Infections in Tertiary Care Teaching Hospital2024-10-24T06:28:33+00:00Ramayanam Navakanth Rajudrnavakanthraju@gmail.com<p>Background: Lower respiratory tract infections (LRTIs) affect the airways and lungs, including conditions such as<br>bronchitis, bronchiolitis, and pneumonia. These infections are a leading cause of mortality from infectious diseases<br>worldwide, often caused by bacterial and viral pathogens. Despite their prevalence, antibiotic prescribing trends in<br>LRTIs remain underexplored, particularly in Indian healthcare settings. Objectives: This study investigates the patterns<br>of antibiotic prescription for LRTIs, including bronchitis, in a tertiary care teaching hospital, with a focus on monoand<br>poly-antibiotic therapies. Methods: A cross-sectional observational study was conducted at Sri Venkateswara<br>Institute of Medical Science, Tirupathi, India. Data were collected from 72 participants, including demographic<br>information, clinical history, and self-medication practices. Statistical analysis was performed using the Statistical<br>Package for Social Sciences software. The study focused on prescription patterns, gender distribution, and the types<br>of antibiotics prescribed. Results: A greater proportion of males than females were found to suffer from LRTIs. Out<br>of the total prescriptions analyzed, 57% were for mono-antibiotic therapy, while 7% involved poly-antibiotic therapy.<br>LRTI diagnoses, including non-specific LRTI, pneumonia, tuberculosis, and pleural effusion, accounted for 76.28% of<br>the cases, with 23.6% of the cases attributed to bronchitis. Augmentin and doxycycline were the two most frequently<br>prescribed antibiotics. A comparison of the prescribed daily dose and defined daily dose of antibiotics was performed.<br>Conclusions: The study highlights the predominant use of mono-antibiotic therapy over poly-antibiotic therapy in<br>treating LRTIs. The findings underscore the need for better antibiotic stewardship to manage the rising number of<br>LRTI patients. Further efforts are required to optimize treatment strategies and reduce the risk of antibiotic resistance.</p>2024-09-15T00:00:00+00:00Copyright (c) 2024 EditorRamayanam Navakanth Raju Rajuhttp://asiapharmaceutics.info/index.php/ajp/article/view/5644Formulation and Evaluation of Lip balm - An Ideal Decorative Cosmetic for Lips2024-10-24T06:40:11+00:00V. Sarovar Reddysarovar.ancp@gmail.com<p>Aims: For decades, cosmetics gained a lot of importance; a day, it would be indispensable for the mankind to maintain<br>health and hygiene with appearance. In the category of cosmetic products, the present investigation focused on lip balm<br>which is a type of lip cosmetics. The aim is to formulate and evaluate the novel lip balm. Materials and Methods:<br>By using ingredients such as beeswax, shea butter, cocoa butter, coconut oil, almond oil, glycerin, orange oil, and<br>a coloring agent. The beeswax was used as a base, and for glossiness, shea butter and cocoa butter as an emollient,<br>coconut oil and almond oil as moisturizing agents, glycerin for a glossy and moisturizing agent, orange oil as a<br>flavoring agent, and turmeric as a coloring agent. A total of 8 formulations were prepared with different compositions<br>ranging from F1 to F8 to select the best formulation for the future scope of study. The prepared formulation for<br>evaluated for suitable parameters such as determination of pH, skin irritation, perfume stability, spreadability, melting<br>point, and breaking point. Results and Discussion: All the formulations show a yellow color appearance with a<br>pleasant odor. The pH for F1 to F8 was in the range of 6.2–6.5, a melting point of 60°–66°C, and a breaking point of<br>28 g–32 g. All the formulations do not show any skin irritation and spreadability shows from average to very good.<br>Conclusion: By considering the results of all the parameters, the F8 formulation was selected as the best formulation.<br>Hence, the F8 formulation met the objective of the present study which may hold promise for future studies</p>2024-10-24T00:00:00+00:00Copyright (c) 2024 V. Sarovar Reddyhttp://asiapharmaceutics.info/index.php/ajp/article/view/5647An Effective Method Employing Alginate- TiO₂ Nanoparticles for Removing Bentazone Herbicide Residues from Water2024-10-24T06:43:43+00:00Y. Prashanthidryprasanthi@gmail.com<p>Our study explored the use of alginate-TiO₂ nanoparticles to effectively remove pesticide residues from water. We<br>synthesized alginate-TiO₂ nanoparticles and characterized them using XRD, SEM, EDS, TEM, and FTIR. We then<br>evaluated their ability to degrade four common bentazone residues in aqueous solutions under various sunlight<br>conditions. Sterile buffer water solutions (pH 4, 7, and 9) containing 1 mg/L bentazone were prepared in a single<br>replicate and stored in clear glass bottles. The bottles were sealed, covered with aluminum foil, and kept in direct<br>sunlight. At periodically, the samples were tested for bentazone concentration using a validated HPLC method.<br>On day 10, the photolysis test showed that 4.21%, 6.83%, and 15.28% of the bentazone had been hydrolyzed in<br>the pH-4, pH-7, and pH-9 buffers, respectively. On day 2, the photocatalysis test using nanocatalyst revealed that<br>89.20%, 90.26%, and 97.12% of the bentazone were catalyzed, respectively. According to the findings, nanocatalyst<br>is an effective decontaminating agent for removing pesticide residues from water. Alginate-TiO₂ nanocatalyst<br>gives cost-effective, efficient, and environmentally friendly alternatives to traditional decontamination methods.<br>Our study suggests that alginate-TiO₂ nanocatalyst is a promising nanomaterial for removing pesticide residues<br>from water, with potential applications in wastewater treatment and environmental remediation. We hope that<br>our findings will encourage further research on this issue and contribute to the development of sustainable and<br>environmentally friendly solutions for enhancing water quality.</p>2024-10-24T00:00:00+00:00Copyright (c) 2024 Y. Prashanthihttp://asiapharmaceutics.info/index.php/ajp/article/view/5649Ameliorative Effects of MnO Nanoparticles on Acute Kidney Injury Model in Rats2024-10-24T06:50:31+00:00Akbar Aliakbar.ahmad@nbu.edu.sa<p>Aims: Acute kidney injury (AKI) is described as an abrupt and generally reversible damage of renal function<br>that occurs over days or weeks. Nearly 20% of nephrotoxicity is associated with the use of antimicrobials and<br>antibiotics. Materials and Methods: The evaluation of the possible protective effect of MnO nanoparticles (NPs)<br>as well as explore their toxic effects on the kidneys of rat models. MnO NPs were prepared and evaluated for their<br>physicochemical properties. The effect of MnO NPs was compared with gentamicin. Results and Discussion: In vivo<br>data showed no toxicity according to zootechnical parameters, blood biochemistry, and organ system toxicity in<br>MnO NP treatment groups. The protective effect of the MnO NPs group as compared to the gentamicin treatment<br>group was observed. Conclusion: Hence, using the MnO NPs will help improve the AKI values.</p>2024-10-24T00:00:00+00:00Copyright (c) 2024 Akbar Alihttp://asiapharmaceutics.info/index.php/ajp/article/view/5650Clinical and Psychological Factors Affecting Distress Among Chronic Warfarin Patients with Uncontrolled International Normalized Ratio - Findings and Implications2024-10-24T06:54:24+00:00Muhammad Shahid Iqbalm.javed@psau.edu.sa<p>Aim: This study aimed to evaluate the clinical and psychological factors of distress among patients on warfarin<br>therapy with uncontrolled International Normalized Ratio (INR) in Pakistan. Materials and Methods: This<br>study used a convenience sampling method to achieve the target size. Perceived distress was measured using<br>a short version of the Cohen Perceived Stress Scale 10. The responses were recorded and statistical analysis<br>was conducted. Results and Discussion: Among the participants, a maximum of the participants were male<br>(n = 280, 68.5%) compared to the females (n = 129, 31.5%). A maximum of the participants were in the above<br>65 years category. Among all the participants, 347 patients showed the presence of low distress and 62 showed<br>the presence of high distress. This result indicates that there is a positive correlation between the age (P = 0.005)<br>and duration of warfarin (P = 0.011) with distress in included patients. Associated comorbidities and history of<br>hospitalization showed no association with distress in the study population. Conclusion: This study reported that<br>warfarin patients in Pakistan experienced a lower level of distress despite their uncontrolled INR. However, few<br>of the factors, such as age and duration of warfarin, were shown to be associated with the higher level of distress<br>in the study participants.</p>2024-09-15T00:00:00+00:00Copyright (c) 2024 Muhammad Shahid Iqbal Iqbalhttp://asiapharmaceutics.info/index.php/ajp/article/view/5651Knowledge, Attitude, Usage Types, and Factors Affecting Dietary Herbal Supplements’ Usage Pattern among Chronic Disease Patients2024-10-24T06:58:18+00:00Muhammad Shahid Iqbalm.javed@psau.edu.sa<p>Aim: This study aimed to assess knowledge, attitude, usage and factors affecting dietary herbal supplements’ usage<br>pattern among chronic disease patients. Materials and Methods: A cross-sectional study was conducted among<br>patients with chronic diseases. This study was conducted using a pre-validated, self-administered questionnaire,<br>designed after an extensive literature review. Results and Discussion: Out of total 134 patients, 120 (89.6%)<br>were males while 14 (10.4%) were females. Our studied patients had very good knowledge about dietary herbal<br>supplements usage (mean knowledge score 7.8 (±3.45)) and majority had relatively positive attitude 103 (76.9%)<br>toward dietary herbal supplements usage. This study found a strong positive correlation between the knowledge<br>and attitude scores (r = 0.903, P = 0.011). Elderly, males, high-income and patients suffering from comorbidities<br>had higher knowledge and positive attitude scores compared to the rest (P < 0.05). The study’s findings showed<br>that the majority of the patients with chronic illnesses used ginger 41 (13.1%), mint 35 (11.2%), fennel 34 (10.9%),<br>and anise 34 (10.5%) as dietary herbal supplements. Conclusion: The good knowledge and moderate to strong<br>attitude toward dietary herbal supplements still emphasized the role of healthcare providers especially clinical and<br>hospital pharmacists to increase awareness about the benefits of dietary herbal supplements among the chronic<br>disease patients suffering from multiple comorbidities.</p>2024-09-15T00:00:00+00:00Copyright (c) 2024 Muhammad Shahid Iqbalhttp://asiapharmaceutics.info/index.php/ajp/article/view/5652Simultaneous Surgery and Management in Patients with Chronic Cholecystitis and Gynecological Diseases2024-10-24T07:02:34+00:00Mamakeev Kanat, Ashimov Zhanybek, Talaibekova Aiperi, Ashimov Isabek, Kadyrov Adilet,Altynai Zhumabekovamamakeevkanatnsc@gmail.com<p>Introduction: Simultaneous surgery for chronic cholecystitis and gynecological diseases is a complex clinical<br>scenario that requires careful consideration of the operation and anesthetic risks involved. This study aimed<br>to evaluate the outcomes of patients who underwent simultaneous operations for these combined conditions<br>at the National Clinical Center of the Ministry of Health of the Kyrgyz Republic between 2019 and 2023.<br>Materials and Methods: A total of 132 patients were divided into two groups based on the surgical approach and<br>volume of the operation: Group I (n = 63, 47.7%) underwent laparoscopic cholecystectomy and gynecological<br>laparoscopy (LC + GL), while Group II (n = 69, 52.3%) underwent LC and open cholecystectomy (LC + OC).<br>Results: The mean age was 53.5 ± 2.8 years for Group 1 and 52.2 ± 2.7 years for Group 2, with no significant<br>age difference between the groups (P > 0.05). The most common gynecological diseases among the patients were<br>uterine fibroids (52.2%), adenomyosis (30.3%), and ovarian cysts (11.4%). In 35 (55.5%) patients who underwent<br>LC, surgeons employed conventional methods for pelvic organ operations, utilizing a 10 mm periumbilical trocar<br>for the laparoscope and two 5 mm trocars in the iliac regions. Conclusion: The results suggest that simultaneous<br>surgery for chronic cholecystitis and gynecological diseases can be performed safely, reducing the patient’s<br>physical burden and treatment and recovery time. However, further research is needed to better understand the<br>risks and benefits of this approach in different patient populations.</p>2024-09-15T00:00:00+00:00Copyright (c) 2024 Mamakeev Kanat Kanathttp://asiapharmaceutics.info/index.php/ajp/article/view/5653Effectiveness of the Lace Method in Osteosynthesis for Hand Fractures in the Kyrgyz Republic2024-10-24T07:05:38+00:00Sultan Tukeshov, Urmat Alybaev, Burulai Emilbekova, Rohini Kaku, Tugolbai Tagaevsultantukeshovksma@gmail.com<p>Introduction: Hand fracture management remains complex, with treatment approaches varying based on fracture<br>type, patient characteristics, and healthcare system constraints. Objectives: This retrospective study aimed to<br>determine the effectiveness of the lace method of osteosynthesis in the Kyrgyz Republic and the anesthetic aspects<br>of this method. Materials and Methods: Patients aged 3–71 years with confirmed wrist fractures were divided<br>into two groups: Group 1 (n = 90) underwent cord osteosynthesis, while Group 2 (n = 34) received standard<br>osteosynthesis treatment. The study compared general and administrative indicators of medical care quality<br>between the groups. Results: Domestic injuries were prevalent in all groups and categories, while work injuries<br>had a more stable distribution. Conductor cells accounted for the majority of anesthesia types in both groups<br>(42.20% in Group 1 and 50.00% in Group 2). Group 1 had a higher percentage of local and general anesthesia,<br>whereas Group 2 had a higher content of conductive anesthesia. The age distribution differed between the<br>groups, with Group 1 primarily composed of children of primary and secondary school age, while Group 2 had a<br>higher proportion of adults aged 18–50 years. Conclusion: The findings suggest differences in the composition<br>of anesthesia used and age distribution between the two groups, which may have implications for treatment<br>outcomes and functional activity. Further research is needed to establish standardized guidelines for hand fracture<br>management and to evaluate the effectiveness of the lace method of osteosynthesis in various patient populations.</p>2024-09-15T00:00:00+00:00Copyright (c) 2024 Sultan Tukeshovhttp://asiapharmaceutics.info/index.php/ajp/article/view/5654Metabolic Matching and Morphofunctional Parameters of Deceased Donor Kidney Transplantation: A Study of Super-Rapid and Delayed Recovery in Asystole Donors2024-10-24T07:10:09+00:00Ashimov Zhanybek, Mamakeev Kanat, Ashimov Isabek, Niyazov Batyrkhan, Akmatov Taalaibek, Yethindra Vityala ashimovisabek@gmail.com<p>Introduction: Deceased donor kidney transplantation is a crucial alternative for patients with end-stage renal<br>disease lacking living donors. This study aimed to characterize the morphofunctional parameters of post-mortem<br>renal allograft (RA ex-mortuo) transplantation when modeling super-rapid recovery and delayed recovery for<br>two types of asystole donors. Materials and Methods: The study assessed the morphological and histochemical<br>parameters of RA ex-mortuo under ex vivo conditions in 39 dogs. The morphological analysis involved kidney<br>biopsies and perfusate examination using light microscopy, morphometric studies, and histostereometric analysis.<br>The study evaluated the height of the renal epithelium in the proximal and distal tubules, the specific volume of<br>glomeruli in the cortex, and the prevalence of dystrophic changes in the tubular epithelium. Lipid peroxidation<br>products in the perfusate were analyzed, and tissue enzyme activity was measured. The study proposed an<br>evaluation algorithm and corresponding criteria to characterize the resource potential of delayed recovery. The<br>effectiveness of RA rehabilitation ex-mortuo was evaluated using a scale based on morphological and metabolic<br>disorder severity. Results: The study pioneered the multicriteria principle to classify asystolic donors as super<br>rapid and delayed recovery, enhancing the understanding of theoretical and practical integration in simulated<br>reality. Using non-perfusion hypothermia ex vivo for rehabilitating RA ex-mortuo requires 60 min to lower basal<br>metabolism, as indicated by reduced succinate dehydrogenase and phenoloxidase activity. Early rehabilitation<br>stages showed decreased metabolism, with enzyme activity significantly decreasing at 30 min. Metabolic disorders<br>were satisfactory at 35 points and mild to severe at 16 points. Conclusion: The activity of key enzymes during<br>ex-mortuo RA rehabilitation showed reduced metabolic processes in both models. Indicators such as AR (−0.09)<br>and AF (0.001%) suggest positive rehabilitation outcomes at both 30 and 120 min, which are closely linked to the<br>temporal risk factor.</p>2024-09-15T00:00:00+00:00Copyright (c) 2024 Ashimov Isabekhttp://asiapharmaceutics.info/index.php/ajp/article/view/5591Orphan Drug Dynamics in India: Challenges, Strategies, and Success Story2024-10-10T08:48:55+00:00Megha Patelpatelmegha5456@gmail.com<p>An orphan drug is the pharmaceutical product formulated to treat rare health conditions. This article provides a comprehensive overview of orphan drugs, focusing on their definition, regulatory status, as well as the challenges and initiatives related to orphan drug development and accessibility in India. It highlights the significant improvements in India’s regulatory framework for orphan drugs, including expedited review processes and exemptions from certain clinical trial requirements. The article also presents a list of orphan drugs sponsored by Indian companies, demonstrating India’s contributions to orphan drug development. Furthermore, it showcases a success story of an orphan drug introduced by Sun Pharmaceutical Industries Limited, emphasizing the importance of research and innovation in addressing unmet medical needs. Finally, future directions in orphan drug research, such as gene therapy and repurposing existing drugs, are discussed, along with the potential of global collaboration and regulatory harmonization to expedite access to innovative therapies for patients worldwide</p>2024-09-25T00:00:00+00:00Copyright (c) 2024 Megha Patelhttp://asiapharmaceutics.info/index.php/ajp/article/view/5592Emerging Trends and Advancements in Pharmaceutical FormulationsTechnologies2024-10-10T08:56:16+00:00Dr Kanaka Durga Devi Nellurinelluriss@rediffmail.com<p>The field of pharmaceutics has seen remarkable advancements in recent years, driven by technological innovations, novel drug delivery systems, and a deeper understanding of drug physicochemical properties. This review highlights the latest developments in pharmaceutics, encompassing drug delivery systems, formulation strategies, and emerging trends. Advanced drug delivery systems, including nano-based carriers and stimuli-responsive platforms, offer precise control over drug release and targeting. Formulation strategies such as solid dispersion technology and lipid-based formulations improve drug solubility and bioavailability. Emerging trends focus on sustainable drug delivery using natural polymers, personalized medicine based on pharmacogenomics, and continuous manufacturing techniques. The integration of interdisciplinary approaches, such as nanotechnology and biotechnology, is driving innovation in pharmaceutical formulations. Overall, these advancements hold promise for enhancing therapeutic efficacy, patient compliance, and addressing medical needs, driving the field of pharmaceutics toward transformative growth</p>2024-09-25T00:00:00+00:00Copyright (c) 2024 Dr Kanaka Durga Devi Nellurihttp://asiapharmaceutics.info/index.php/ajp/article/view/5593Nutraceuticals: A Holistic Approach to Health2024-10-10T09:03:45+00:00Dilsar Gohilgohildilsar9624@gmail.com<p>Nutraceuticals, bridging nutrition and medicine, form a billion-dollar global industry. With dissatisfaction over costly medical treatments, consumers turn to healthier diets and nutraceuticals for an alternative. Recent scientific advances introduce concepts such as nutraceuticals, promising disease prevention, and reduced health-care costs. These compounds, categorized by natural sources, offer personalized, long-term solutions with a focus on holistic health. They play key roles in managing conditions from cardiovascular issues to neurodegenerative diseases, reducing oxidative stress, inhibiting cancer cell growth, and boosting cognitive function. As we look forward, genetics and personalized medicine will customize nutraceutical interventions, and the market for functional foods and plant-based nutraceuticals will expand as consumers seek healthier options. Ongoing research, technology, and regulatory standards will continue shaping healthcare’s future, making nutraceuticals a key player in disease prevention and holistic well-being</p>2024-09-25T00:00:00+00:00Copyright (c) 2024 Dilsar Gohilhttp://asiapharmaceutics.info/index.php/ajp/article/view/5594Telemedicine: Advancing Smarter by Evolution through Decades2024-10-10T09:13:36+00:00Mohd Imranimran.pchem@gmail.com<p>Telemedicine has undergone significant transformation over the past several decades, evolving from rudimentary communication tools to sophisticated digital health platforms. This manuscript examines the historical progression, technological advancements, and broad applications of telemedicine, highlighting its impact on health-care delivery. A systematic review of literature and case studies was conducted, focusing on the technological, regulatory, and clinical aspects of telemedicine. Key sources include peer-reviewed journals, official health organization reports, and case studies demonstrating practical applications of telemedicine. The evolution of telemedicine is closely linked with advancements in communication technologies, including the Internet, mobile devices, and artificial intelligence. These technologies have enhanced the accessibility, reliability, and functionality of telemedicine platforms. Telemedicine has significantly improved health-care delivery, particularly in remote and underserved areas. It has enabled remote consultations, diagnostics, chronic disease management, and mental health services, thus increasing patient access and continuity of care. Telemedicine represents a transformative shift in health-care delivery, offering enhanced patient care, improved access, and cost efficiencies. Its evolution reflects continuous innovation, increased acceptance, and supportive regulatory environments. Future efforts should focus on overcoming existing challenges and leveraging emerging technologies to further integrate telemedicine into the health-care ecosystem. The potential applications of telemedicine extend beyond traditional health-care settings, promising smarter, more efficient, and more equitable health care for all</p>2024-09-25T00:00:00+00:00Copyright (c) 2024 Mohd Imranhttp://asiapharmaceutics.info/index.php/ajp/article/view/5596Leveraging the Potential Benefits of Medicinal Plants in the Management of Substance Abuse2024-10-10T09:27:07+00:00Syed Mohammed Basheeruddin Asdaqsasdag@um.edu.sa<p>There is a global increase in the number of reported cases of drug misuse and addictions. In addition to several health<br>issues, the addict-forming substance affects society economically. Cocaine, heroin, opium, alcohol, nicotine, and<br>marijuana are a few of the major substances that are abused. These agents’ inexpensive cost and wide availability<br>contribute to their abuse. Many conventional medications are available to treat substance abuse-related disorders,<br>but they come with several side effects. One potential treatment option for the issues experienced by addicts is<br>the use of alternative medications obtained from natural sources. The current study provided an overview of<br>a few published studies that suggested herbal medication may be effective in reducing withdrawal symptoms.<br>The information was obtained from the Web of Science, NCBI, PUBMED, EMBASE, and Google Scholar. The<br>retrieved data were analyzed to determine the active constituent present in the plant material, the type of addict<br>substance tested, and the possible mechanism identified. The research identified some of the plants that have been<br>reported to be effective in the management of substance abuse complications. Information analysis revealed that<br>plant-based medications helped lessen anxiety, pain, insomnia, and deviant conduct, among other consequences of<br>substance usage. Withdrawal as well as dependence liabilities due to addictive agents were found to be reduced.<br>The plant-based medicines exhibited their action on brain centers involving dopaminergic, serotonergic, and<br>adrenergic transmission. The observations from the study revealed that herbal medicines were effective in the<br>management of substance abuse complications. However, most of the investigations were conducted using preclinical testing models. Therefore, it can be said that while herbal medications showed promise in treating drug<br>abuse-related problems, further study is necessary to pinpoint the exact safety and effectiveness of these agents.</p>2024-09-15T00:00:00+00:00Copyright (c) 2024 Syed Mohammed Basheeruddin Asdaqhttp://asiapharmaceutics.info/index.php/ajp/article/view/5614Microsponge: A Novel Approach for Topical Drug Delivery of Anti Rheumatoid Drugs2024-10-24T05:03:04+00:00Krupa Joshikrupaj356@gmail.com<p>Microsponge is one of the developing fields of science innovation, which can be capable of both regulated drug<br>delivery and site-specific administration of drugs. The determination of the particular pharmaceutical formulations<br>and way of distribution for delivery of the medicament is strongly influenced by the physical and chemical<br>characteristics of the microsponge, such as the size of particles, distribution of particle size, transparency, and<br>surface structure. An innovative technique for topical medicine delivery has also emerged: The microsponge. The<br>topical methods further benefit from flexible formulations, more patient participation, increased safety and overall<br>performance, and attractive characteristics. Immunomodulatory rheumatoid arthritis requires long-term therapy<br>to control the condition. Long-term administration of the marketed oral dosage forms may result in liver damage.<br>The topical way may represent a good alternative method for medication delivery with better drug stability, less<br>adverse effects, and less frequent administration. Microsponges have the ability to entrap significant amounts of<br>dosage and may also alter medication release due to its porous and spongy nature.</p>2024-10-24T00:00:00+00:00Copyright (c) 2024 Krupa Joshihttp://asiapharmaceutics.info/index.php/ajp/article/view/5615Emerging Innovations in Stimuli- Responsive Drug Carriers for Targeted Therapeutic Delivery2024-10-24T05:06:51+00:00Nadeem Siddiquisiddiqui@kluniversity.in<p>Targeted drug delivery has revolutionized modern medicine by enabling the precise delivery of therapeutics to<br>specific sites while minimizing systemic side effects. This comprehensive review explores recent advancements<br>in targeted drug delivery systems, focusing on nanotechnology-based approaches, stimuli-responsive carriers,<br>and innovative targeting strategies. Nanoparticles, including liposomes, polymeric nanoparticles, and inorganic<br>nanoparticles, offer enhanced drug solubility and targeted delivery to specific tissues or cells. Stimuli-responsive<br>drug carriers respond to environmental cues, allowing for controlled drug release. Targeting strategies employ<br>ligands to bind to receptors on target cells, enabling precise delivery of therapeutics. Applications span various<br>diseases, including cancer, neurological disorders, infectious diseases, and chronic conditions. Despite challenges<br>such as biocompatibility and regulatory considerations, targeted drug delivery holds promise for personalized<br>medicine, improving therapeutic efficacy, and patient outcomes.</p>2024-09-15T00:00:00+00:00Copyright (c) 2024 Nadeem Siddiquihttp://asiapharmaceutics.info/index.php/ajp/article/view/5616Recent Advances in Artificial Intelligence Applications in Pharmacy Practice2024-10-24T05:10:13+00:00Abidaaqua_abkhan@yahoo.com<p>The health-care industry is only one of several that has benefited from the revolutionary technology known as<br>artificial intelligence (AI). AI might greatly enhance pharmaceutical practice by better-managing medications<br>and patient care. Several AI applications in pharmacy practice are examined in this study. Using AI technology,<br>chemists are equipped with methods and tools that enable them to make clinical judgments based on reliable<br>evidence. Pharmacists can now analyze vast amounts of patient data, such as medical records, laboratory<br>results, and medication profiles, with the help of AI algorithms and machine learning. This allows them to<br>better assess the safety and effectiveness of medications, identify possible drug-drug interactions (DDIs), and<br>make recommendations based on patient needs. Predicting and detecting adverse drug events, automating<br>dispensing processes in community pharmacies, optimizing medication dosages, detecting DDIs, improving<br>adherence through smart technologies, detecting and preventing medication errors, providing medication therapy<br>management services, and supporting telemedicine initiatives are all possible with the help of specific AI models.<br>Integrating AI into clinical practice allows health-care providers to enhance patient care through personalized<br>decision-making. Various health-care services offered to a single patient may work together more effectively with<br>the help of AI. When it comes to medication, AI could help patients remember to take their medication at the<br>right times, educate them on the importance of taking their medication as prescribed, and increase the likelihood<br>that they will take their medication as prescribed. AI could also help patients find the most affordable health-care<br>options, improve their communication with health-care providers, optimize their health monitoring with wearable<br>devices, offer guidance on healthy lifestyle choices every day, and even incorporate exercise and diet into their<br>treatment plans.</p>2024-09-15T00:00:00+00:00Copyright (c) 2024 Abidahttp://asiapharmaceutics.info/index.php/ajp/article/view/5617A Contemporary Use of Generic drugs in the Healthcare System2024-10-24T05:12:47+00:00Neeta Raineeta.rai@vupune.ac.in<p>The term “drugs” or “medicines” refers to substances used in the treatment, diagnosis, mitigation, and prevention<br>of disease. However, the price is high. Not for everyone, however, the expense of the medications makes receiving<br>therapy very challenging for lower and middle-class individuals. The patient’s inability to pay for the cost of<br>the medications contributes to a great number of deaths. The health-care system underwent a revolution when<br>generic medications entered the market, and their market share is still growing today. Because these are genuine,<br>trustworthy, safe, affordable, and available to everyone, society’s poor and needy groups benefit. Now, there<br>is a substitute for expensive branded medications. The Indian government is doing a lot to increase access to<br>generic medications in both urban and rural areas, as well as to raise awareness among the public that these<br>medications are just as effective and safe as name-brand medications. Generic medications are produced by<br>numerous pharmaceutical companies and distributed through retail outlets. In addition, operating and delivering<br>generic medications to customers’ homes are e-pharmacies. Numerous Pradhan Mantri Bhartiya Janaushadhi<br>Kendra (PMBJK) locations have been established by the government nationwide, where people can get generic<br>medications for a significantly reduced price. The history of generic medicine shows, how the prices are less than<br>standard medicines and how it can be beneficial for economic factors.</p>2024-09-15T00:00:00+00:00Copyright (c) 2024 Neeta Raihttp://asiapharmaceutics.info/index.php/ajp/article/view/5618Medicinal Properties and Therapeutic Potential of Fagonia arabica Linn: A Comprehensive Review2024-10-24T05:15:09+00:00Gurmeet Kaur Surindar Singhgurmeet9952@uitm.edu.my<p>Fagonia arabica, commonly known as “Dhamasa,” is revered in Ayurveda for its multifaceted medicinal properties.<br>Widely used in South Asia and the Middle East, it has been a staple in traditional medicine systems such as Ayurveda<br>and Unani. In this review, a comprehensive search was performed using various scientific databases, including<br>PubMed, Scopus, and Google Scholar. Keywords such as “Fagonia Arabica Linn,” “therapeutic potential,” “medicinal<br>properties,” and “phytochemical constituents” were employed to ensure a comprehensive retrieval of relevant literature.<br>The extensive literature analysis showed that F. arabica has been long utilized in Middle Eastern and South Asian<br>populations for the treatment of a variety of illnesses, as well as in Ayurvedic and Unani medicine. The plant exhibits a<br>rich history of ethnopharmacological uses across diverse geographic regions. From being a diuretic in India to treating<br>skin diseases and wounds, F. arabica’s applications are varied. In Pakistan, it is employed for treating hepatitis, and<br>fever, and even serves as an immunomodulator. The plant’s extensive use encompasses regions such as Libya and Saudi<br>Arabia, where it is used as an antihypertensive, antibacterial, and antioxidant. The chemical composition of F. arabica<br>includes flavonoids, triterpenoidal glycosides, and saponins. These compounds contribute to the plant’s antioxidant<br>activity, making it a potent natural remedy. F. arabica has a spectrum of pharmacological activities, including<br>anti-inflammatory, anti-allergic, neuroprotective, and cytotoxic activity. The plant’s role as an immunomodulator,<br>deobstruent, analgesic, neuroprotective, and hepatoprotective adds to its pharmacological significance. F. arabica<br>stands as a medicinal marvel with a rich history of traditional use and a promising array of pharmacological benefits</p>2024-09-15T00:00:00+00:00Copyright (c) 2024 Gurmeet Kaur Surindar Singhhttp://asiapharmaceutics.info/index.php/ajp/article/view/5619Role of Pharmacists and Nurses to Avoid Physicochemical Drug Interactions to Ensure Patient Safety2024-10-24T05:20:19+00:00Mohd Imranimran.pchem@gmail.com<p>Healthcare professionals such as nurses and pharmacists play a vital role in patient care. The paper underscores<br>the roles of nurses and pharmacists in reducing physicochemical drug interaction and improving patient safety<br>thereby improving the overall healthcare system. A comprehensive literature analysis was done to investigate the<br>impact of physicochemical drug interactions, the responsibilities of nurses and pharmacists in minimizing these<br>interactions, and the value of multidisciplinary teamwork. The study also contains therapeutic recommendations<br>for avoiding drug-drug, drug-food, and drug-nutrient interactions. There has been an increasing rate of medication<br>error due to the physicochemical interaction of the drugs. The unexpected side effects during patient treatment<br>are particularly concerning, as they can elevate mortality and morbidity rates while driving up therapeutic costs.<br>The data show that approximately 50% of pharmaceutical mistakes are caused by physicochemical interactions,<br>particularly in intravenous dose forms. Nurses and pharmacists can work together to prevent these errors by<br>checking medication compatibility, continuously monitoring patient reactions, and revising compatibility<br>recommendations. As a team, pharmacists can examine prescriptions to avoid contraindicated drug combinations,<br>while nurses, as frontline caretakers, ensure that drugs are administered correctly and the food administered to the<br>patient does not negatively interact with the medications. Both experts must work together to discover and avoid<br>physicochemical incompatibilities, which improves patient safety and lowers healthcare costs. This coordinated<br>approach is critical for reducing prescription mistakes while improving the overall stability and efficacy of<br>pharmacological formulations in patient care.</p>2024-09-15T00:00:00+00:00Copyright (c) 2024 Mohd Imranhttp://asiapharmaceutics.info/index.php/ajp/article/view/5620Antiviral Efficacy of Tinospora cordifolia – A Review2024-10-24T05:26:42+00:00Kanyaga Parameshwarikanyagasasi@gmail.com<p>Since ages, plants have had a pivotal role as medicine due to their therapeutic value. Tinospora cordifolia is a<br>well-known plant with versatile medicinal properties including hypoglycemic, anti-inflammatory, antioxidant,<br>immunomodulatory, and antimicrobial, which can be attributed to its secondary metabolites. Viral infections<br>constitute a major faction of human diseases. Developing efficient and novel therapeutic agents to combat viral<br>diseases is an ongoing process, wherein plant-derived natural products are a potential source. T. cordifolia has<br>been explored for its use in viral infections as an immunomodulatory and antiviral agent. Bioactive components of<br>the plant, such as berberine, tinosponone, tinocordiside, isocolumbin, magnoflorine, tinosporin, and cordiofoliside<br>have been reported to exhibit antiviral efficacy. The present review summarizes the efficacy of T. cordifolia as an<br>anti-viral agent and its role in combating viral infections.</p>2024-09-15T00:00:00+00:00Copyright (c) 2024 Uma Duttahttp://asiapharmaceutics.info/index.php/ajp/article/view/5621Recent Advancements and Therapeutic Applications of the Niosomal Drug Delivery System2024-10-24T05:30:41+00:00Mayur R. Dandekarmayurdandekar1727@gmail.com<p>Niosomes are a novel class of creative vesicular structures. They are made of biodegradable and essentially<br>harmless non-ionic surfactants. They were created as more affordable and reliable alternatives to liposomes.<br>Their function has expanded to include various application areas since they were first introduced to the cosmetics<br>sector. They are currently being investigated as prospective medication delivery systems for focused and sustained<br>delivery. They can be administered through ocular, transdermal, vaginal, and inhalation in addition to traditional,<br>oral, and parenteral methods. Niosome delivery of biotechnological goods, like vaccines, is another fascinating<br>and promising study topic. These systems have become even more relevant in developing a particular strategy<br>in the form of proteasomes. Further, focused research efforts are still needed to fully exploit these innovative<br>technologies. With a focus on their function in drug targeting, this review examines the current state and promise<br>of niosomes in drug delivery. Their preparation techniques, formulation features, benefits, drawbacks, and<br>applications are also described.</p>2024-09-15T00:00:00+00:00Copyright (c) 2024 Mayur R. Dandekarhttp://asiapharmaceutics.info/index.php/ajp/article/view/5622Advancing Knowledge with Ultraviolet- Spectroscopy: Recent Trends and Future Insights2024-10-24T05:37:11+00:00Mayur R. Dandekarmayurdandekar1727@gmail.com<p>One popular analytical method for looking at molecules’ electronic transitions is UV-Vis spectroscopy. The theoretical<br>foundations of UV-Vis spectroscopy, including the theory of molecular orbits and the kinds of electronic transitions<br>that cause absorption in the UV and visible spectrums, are examined in this review article. It also discusses the<br>variables that affect absorption spectra, including conjugation, chromophores, and solvent effects. Important uses<br>such as statistical analysis, molecular structure identification, and conjugated system research are also highlighted in<br>the text. It is explored what the future holds for UV-Vis spectroscopy in both industry and research.</p>2024-09-15T00:00:00+00:00Copyright (c) 2024 Mayur R. Dandekarhttp://asiapharmaceutics.info/index.php/ajp/article/view/5623Pharmaceutical Quality Control and Assurance in the 21st Century2024-10-24T05:40:19+00:00Mayur R. Dandekarmayurdandekar1727@gmail.com<p>In the 21st century, the pharmaceutical industry faces dynamic and ever-evolving challenges that demand a<br>robust commitment to quality control and assurance. This review article delves into the multifaceted landscape<br>of pharmaceutical quality, highlighting plays’ critical role in ensuring medication safety and efficacy. As the<br>pharmaceutical world experiences profound shifts driven by technological advertisement, global supply chains,<br>and regulatory updates this article offers an in-depth exploration of the key facets that define quality control and<br>assurance in this era. Regulatory oversight has significantly transformed, with agencies such as the FDA and<br>EMA adapting to keep pace with the industry’s changing dynamics. We examine the current regulatory landscape,<br>its impact on quality standards, and the growing emphasis on transparency and compliance. Advertisements<br>in analytical techniques have revolutionized quality control, from mass spectrometry and nuclear magnetic<br>resonance to sophisticated spectroscopy methods. This article explores these advanced tools and their contribution<br>to product quality. Quality by design (QbD) principles have gained traction, advocating a proactive approach to<br>quality control by integrating it into the product development process. We discuss the implications of QbD and<br>its tangible benefits. Looking to the future, we predict emerging trends that will continue to shape pharmaceutical<br>quality control and assurance technology such as blockchain and 3D printing are expected to play pivotal roles.<br>In conclusion, this comprehensive review serves as a vital resource for professionals, researchers, and playmakers<br>seeking a nuanced understanding of the ever-evolving terrain of pharmaceutical quality control and assurance. It<br>emphasizes the critical importance of adapting to meet modern challenges and seizing opportunities for innovation<br>in the pursuit of pharmaceutical excellence.</p>2024-09-15T00:00:00+00:00Copyright (c) 2024 Mayur R. Dandekarhttp://asiapharmaceutics.info/index.php/ajp/article/view/5625A Comprehensive Review on the Recent Applications and Development in Nanocarriers2024-10-24T05:43:30+00:00Nikhita Chambharenikita.pharmacy@dmiher.edu.in<p>Nanocarriers have shown promise as effective delivery vehicles. Controlled release, and enhanced efficacy of<br>therapeutics, imaging agents, and functional payloads in various applications. An overview of the synthesis<br>processes, characterization methodologies, and uses of nanocarriers in agriculture, environmental sustainability,<br>and healthcare is given in this abstract. Common types of nanocarriers, including liposomes, polymeric<br>nanoparticles, dendrimers, and metal-based nanoparticles, are discussed, along with their synthesis methods and<br>key properties. Characterization techniques such as transmission electron microscopy, dynamic light scattering,<br>Fourier-transform infrared, and cell viability assays are highlighted for evaluating the physicochemical properties,<br>stability, and biocompatibility of nanocarriers. Applications of nanocarriers in drug delivery, diagnostics, gene<br>therapy, agriculture, and environmental remediation are explored, showcasing their potential to address critical<br>challenges and improve human health and environmental sustainability. Despite their promise, nanocarriers<br>face challenges such as biocompatibility concerns, stability issues, and regulatory considerations, necessitating<br>interdisciplinary collaboration and rigorous safety assessments for their successful translation into practical<br>use. Looking ahead, nanocarriers hold tremendous promise for personalized medicine, combination therapies,<br>smart and stimuli-responsive systems, theragnostic, and sustainable solutions, shaping a future where precision,<br>efficiency, and tailored solutions transform healthcare, agriculture, and environmental management. To fully<br>utilize nanocarrier technology and advance science, health, and technology for the good of society, more funding,<br>cooperation, and research will be needed.</p>2024-09-15T00:00:00+00:00Copyright (c) 2024 Nikhita Chambharehttp://asiapharmaceutics.info/index.php/ajp/article/view/5626Review on Face Serum2024-10-24T05:47:30+00:00Sunita Vaidyasunitavaidya06@gmail.com<p>Face serums are specialty skincare concoctions that target particular issues and produce noticeable results by<br>deeply delivering powerful active ingredients into the skin. These thin, highly concentrated products are usually<br>made with a combination of healthy ingredients such as retinol, hyaluronic acid, Vitamin C, or alpha-hydroxy acids.<br>Depending on how they are made, face serums can have a wide range of effects, but they frequently have hydrate,<br>anti-aging, brightening, exfoliating, soothing, and oil-control properties. You can address your specific skincare<br>concerns and achieve healthier, more radiant skin by adding the right serum to your skincare routine. Over the<br>past 10 years, the cosmetics industry has consistently expanded. The large and expanding youth population is one<br>of the main factors driving growth in this category. Indian women today are more concerned with keeping their<br>skin youthful and radiant by minimizing wrinkles and changing the color of their skin. This has led to an increase<br>in the market for skin care products of all kinds. Like any other cream, serum is a highly concentrated product<br>based on water or oil. A small number of ingredients in the serum are intended to maximize the availability of the<br>active ingredient, which could be a growth factor, vitamin, botanical extract, etc. Because the serum has a lower<br>viscosity, it absorbs more quickly and penetrates the skin’s deep layers to target different areas and provide the<br>most nourishing skin. Face serums address a variety of skincare needs by providing hydration, anti-aging benefits,<br>brightening effects, exfoliation, soothing qualities, and oil control. Face serums, which provide customized<br>solutions for attaining healthier, more radiant skin, have become essential components of contemporary skincare<br>routines due to their lightweight texture and potent efficacy. Photodamage and ultraviolet exposure can cause<br>unwanted outcomes such as wrinkles on the face and aging of the skin. The deep formula of the serum has a high<br>concentration of active ingredients, a non-greasy finish, quick absorption, and the capacity to penetrate the skin’s<br>deep layers. The goal of the research was to create a serum using a polyhedral extract based on these features.<br>Face serum is a highly concentrated cosmetic product made of olive oil, betel fruit extract, and Aloe vera gel.<br>Face serum made with A. vera, bael fruit extract, and olive oil is a very potent cosmetic. A. vera serum can absorb<br>quickly and penetrate deeper, which gives us immediate cosmetic benefits as well as psychological satisfaction.</p>2024-09-15T00:00:00+00:00Copyright (c) 2024 Sunita Vaidyahttp://asiapharmaceutics.info/index.php/ajp/article/view/5628Self-emulsifying Drug Delivery System for Improvement of Solubility of Drug2024-10-24T05:52:10+00:00Manjusha Bhangemanjusha.pharmacy@dmiher.edu.in<p>In this review, we examine the solubility properties of compounds and the different ways to improve solubility for<br>more efficient action. We also address the common variables that affect solubilities, such as polarity, polymorphs,<br>molecular size, temperature, pressure, wildlife of the solute and flush, and particle scope. To overcome these<br>solubility problems, various approaches have been taken to increase solubility. These include physical modification,<br>chemical modification, and miscellaneous methods. One of the most efficient techniques we discuss is the Self-<br>Emulsifying Medicine Transfer Scheme (self-emulsifying drug delivery system), which is suitable for emulsions<br>with droplet sizes around 100 nm to 300 nm. We also discuss the further modification of SEDDS, which is the selfmicro<br>blending medication transfer system (self-microemulsifying drug-delivery system). SMEDDS is useful for<br>droplet sizes around or near 50 nm, and we compare its advantages and disadvantages with those of emulsions. We<br>also cover the criteria for selecting excipients such as oil, surfactant, and solvents for the groundwork of SEDDS<br>and SMEDDS. In addition, we discuss the methods of preparation of emulsions and their characterization. Finally,<br>we examine the different techniques for solidifying liquid/semisolid emulsions into solid preparations along with<br>their advantages and disadvantages. We conclude with a list of dosage forms for oral administration. This review<br>provides a comprehensive analysis of the solubility properties of compounds, focusing on the different approaches<br>to enhance solubility for more efficient action. We also delve into the common variables that affect solubilities,<br>including polarity, polymorphs, molecular size, temperature, pressure, countryside of the solute and solvent,<br>and particle magnitude. To overcome these solubility problems, various approaches have been taken to increase<br>solubility. These include physical modification, chemical modification, and miscellaneous methods. Among these,<br>the Self-Emulsifying Treatment Delivery Scheme (SEDDS) stands out as an efficient technique that is suitable<br>for emulsions with droplet sizes around 100 nm to 300 nm. Furthermore, we discuss the Self-Micro Emulsifying<br>Preparation Transfer Organization (SMEDDS), which is a further modification of SEDDS and offers advantages<br>over emulsions. We also provide an in-depth analysis of the criteria for selecting excipients such as oil, surfactant,<br>and solvents for the training of SEDDS and SMEDDS. In addition, we explore the methods of preparation of<br>emulsions and their characterization. Finally, we examine the different techniques for solidifying liquid/semisolid<br>emulsions into solid preparations, highlighting their advantages and disadvantages. We conclude with a list of<br>dosage forms for oral administration. This review aims to provide a comprehensive guide for researchers and<br>professionals to overcome solubility issues and enhance solubility for more efficient drug delivery.</p>2024-09-15T00:00:00+00:00Copyright (c) 2024 Manjusha Bhangehttp://asiapharmaceutics.info/index.php/ajp/article/view/5629Targeted-based Nanocarriers for Control of Non-Hodgkin Lymphoma: Current Aspects and Future Perspectives2024-10-24T05:56:09+00:00Monika S. Hiwaremonikahiware1@gmail.com<p>Oncology faces many challenges with non-Hodgkin lymphoma (NHL) a varied group of lymphatic system<br>tumors. Immunotherapeutic methods have supplemented or replaced chemotherapy for NHL treatment. Immune<br>checkpoint inhibitors improve NHL patient outcomes and quality of life. CAR-T cell treatments also enhance<br>patient prospects. Monoclonal antibody therapy is advancement. Several treatments are still used. Radiation<br>therapy is a part of this. Multimodal therapy approaches also include stem cell transplantation. The study also<br>examines treatment resistance and long-term side effects. Nano medicine uses nanomaterial’s to treat cancer.<br>Oncology entered a new age. This study gives hope for nanomaterial-based NHL treatment. A treatment more<br>successful, focused and humane.</p>2024-09-15T00:00:00+00:00Copyright (c) 2024 Monika S. Hiwarehttp://asiapharmaceutics.info/index.php/ajp/article/view/5631Microneedles for Proteins and Peptides Delivery: Current Aspect and Future Perspective2024-10-24T05:59:31+00:00Renuka Pattewarrenukapattewar285@gmail.com<p>More than half of the top 20 most famous drugs fall under biopharmaceuticals, with projections indicating a $388<br>billion value by 2024 that shows how effective protein, peptide, and antibody-based treatments are. However, the<br>methods for effective medication delivery have been limited by the inherent characteristics of biopharmaceuticals.<br>Although the intravenous route offers 100% bioavailability, patients frequently link it with discomfort and needle<br>anxiety, which might result in resistance to receiving necessary therapy. Since then, several non-invasive techniques<br>have been developed to get beyond these restrictions. One such tactic is microneedles (MNs), which can painlessly<br>pierce the stratum corneum barrier and significantly improve transdermal medication delivery of various medicines.<br>This review summarizes several studies that strive to enhance MN-based transdermal biopharmaceutical delivery.<br>The ability to increase MN production at a lower cost and the application’s long-term safety will be key factors<br>in determining the full potential of MNs as a drug delivery technology for biopharmaceuticals. Thus, the existing<br>obstacles to the clinical translation of MNs are also examined, along with potential solutions.</p>2024-09-15T00:00:00+00:00Copyright (c) 2024 Renuka Pattewarhttp://asiapharmaceutics.info/index.php/ajp/article/view/5633Potentials of Hydrogel in Tissue Engineering: An Overview2024-10-24T06:03:12+00:00Bindu Vijaybvijay@gnlu.ac.in<p>Over the years, the demand for tissue and organs has grown due to accidents and other disease conditions.<br>Tissue repair and restoration are vital for maintaining the body’s integrity. However, the biggest challenge in<br>tissue damage and repair has been finding an alternative cell/tissue for damage repair. Tissue engineering has<br>proven successful in this field. Its primary objective lies in the creation of synthetic alternatives that bear close<br>resemblance to natural tissues. Today, tissue regeneration from synthetic alternatives is successfully considered<br>for treating several types of tissue damage and repair, including chronic kidney disease. This paper aims to give an<br>overview of tissue engineering, emphasising hydrogel as a potential biomaterial for tissue engineering.</p>2024-09-15T00:00:00+00:00Copyright (c) 2024 Bindu Vijayhttp://asiapharmaceutics.info/index.php/ajp/article/view/5635Herbal Extract Nano-formulation for Huntington’s disease Treatment2024-10-24T06:06:40+00:00Sapana A. Patilsapanapatel1112@gmail.com<p>The hallmark of Huntington’s disease (HD), an autosomal dominant genetic disorder, is degeneration of neurons<br>of central nervous system (CNS). Tranquilizers, antipsychotics, antidepressants, and monoamine depletors are<br>among the often utilized in treatments. These medications, however, are unable to stop the behavioral, cognitive,<br>and psychotic disorders linked to HD. Moreover, their long-term negative effects restrict their continuous use. Still,<br>due to their limited drug solubility and penetration to the target site, herbal medicines are unable to advance the<br>phase of clinical investigation. Herbal formulation and extracts that show potential in neurotoxic HD models must<br>have their active ingredients and underlying mechanisms of action thoroughly investigated. Several plants that are<br>known to be CNS-active medications, such as Bacopa monnieri, Ginkgo biloba, Panax ginseng, Cannabis sativa,<br>and Curcuma longa L. were listed as the most promising anti-HD options. In the past few decades, it has been a<br>paradigm shift in research toward the creation of nanoformulations based on herbal medications that can improve<br>their permeability through blood-brain barrier and bioavailability. This review addresses the phytomedicines<br>investigated against HD, current clinical studies on herbal medications used only for HD treatment, and the<br>possible neuroprotective effects of these drug’s nanocarriers.</p>2024-09-15T00:00:00+00:00Copyright (c) 2024 Sapana A. Patilhttp://asiapharmaceutics.info/index.php/ajp/article/view/5636Beyond Menopause - Navigating Holistic Approach in Managing Dry Eyes2024-10-24T06:10:43+00:00B. N. Ashwinidrashwinibelludi@gmail.com<p>Among all ocular conditions, dry eye remains one of the most prevalent in clinical practice, ranging from 5% to<br>50% with higher variations in signs than symptoms. Increased age, female sex, and Asian ethnicity are among<br>the most consistent risk factors for developing dry eye disease. The prevalence of dry eye increased by 14.4%<br>in people aged 48–91, with the prevalence of the disorder more than doubling after the age of 59. Females are<br>more prone to develop dryness, especially in the post-menopausal age group. Sex hormones play a key role in<br>maintaining the homeostasis of the tear film. Hence, older women tend to develop dry eyes more than the other<br>age groups. Considering the clinical features of dry eyes and analyzing the diseases in Ayurveda Netra Roga, the<br>disease closely resembles the condition Shushkakshipaka Dosha predominance according to Sushruta is vata and<br>Vagbhata explains it as vata pitta pradhanavyadhi. Aggravation of vata and pitta dosha leads to the shoshana of<br>nethragatasneha contributed by kapha dosha. Considering the age and ritunivrutii kala (menopausal age), both are<br>dominated by vata and also the disease. In consideration with the normal dry eyes population, this age group needs<br>special consideration in addressing both post-menopausal dry eyes and other menopause-related issues. Hence,<br>this review is planned to establish the correlation between dry eyes and shushkakshipaka to explore a better<br>alternative treatment for post-menopausal dry eyes, and improve overall health in this population.</p>2024-09-15T00:00:00+00:00Copyright (c) 2024 B. N. Ashwinihttp://asiapharmaceutics.info/index.php/ajp/article/view/5638A REVIEW ON MICROSPHERES AS DRUG CARRIERS2024-10-24T06:15:08+00:00Sunita N. Vaidyasunitavaidya06@gmail.com<p>Orally modified-release multiple-unit dosages have consistently shown themselves to be a more successful therapeutic<br>choice than other dosage types. Novel medication delivery systems have several advantages over conventional<br>multidose therapy. Current trends indicate that the use of micro particles in drug delivery systems can result in<br>regulated or delayed release formulations for oral use with minimal risk of dose dumping, variable blending to achieve<br>different release patterns, and predictable and short stomach residence time. In addition to their prolonged release,<br>microspheres garnered significant interest for their capability to specifically target drugs. It has been demonstrated<br>that oral modified-release multiple-unit dosage is a more efficacious treatment option in comparison to traditional or<br>quick-release single-unit dosage forms. Innovative drug delivery methods are superior to traditional multidose therapy<br>in a number of ways. According to current trends, the use of microparticles in drug delivery systems can lead to<br>formulations that are regulated or released gradually for ingestion with a low risk of dose dumping, blending that can<br>be adjusted to achieve diverse release patterns, and a stomach residence period that is predictable and brief. In addition<br>to their extended release, microspheres attracted a lot of attention due to their capacity to target medications precisely.</p>2024-09-15T00:00:00+00:00Copyright (c) 2024 Sunita N. Vaidyahttp://asiapharmaceutics.info/index.php/ajp/article/view/5639Enhancing Medication Solubility Using Nanosuspension: A Method2024-10-24T06:18:11+00:00Isha A. Mirzapureishamirzapure22@gmail.com<p>Its extremely low bioavailability is the main problem with poorly soluble medicines. The presence of medications<br>such as carbamazepine, simvastatin, and itraconazole – which are insoluble in both watery and non-aqueous<br>solutions and belong to the BCS class II of the pharmacological classification system – complicates matters even<br>more. Formulation as nanosuspension is a desirable and feasible answer to these problems. The drug is distributed<br>as a so-called nanosuspension, which is a pure, poorly water-soluble drug without any matrix components. The<br>simple synthesis of nanosuspensions can be advantageous for all drugs that are soluble in water. A nanosuspension<br>changes a drug’s pharmacokinetics, boosting safety and efficacy in addition to improving the drug’s soluble<br>condition and low bioavailability. The preparation techniques, article description, and review findings.</p>2024-09-15T00:00:00+00:00Copyright (c) 2024 Isha A. Mirzapurehttp://asiapharmaceutics.info/index.php/ajp/article/view/5641Revolutionizing Glaucoma Care: Innovative Latanoprost Drug Delivery Takes Aim at Vision Loss2024-10-24T06:22:17+00:00Shivani R. Makhijanishivanimakhijani17@gmail.com<p>Glaucoma remains one of the leading causes of irreversible blindness worldwide, presenting a significant public<br>health challenge. Current glaucoma management primarily relies on eye drops, with prostaglandin analogs, such<br>as latanoprost being a cornerstone of treatment. However, patient adherence, ocular side effects, and the need<br>for consistent dosing pose substantial obstacles to effective care. This review paper introduces a groundbreaking<br>approach to glaucoma management through innovative latanoprost drug delivery. By leveraging cutting-edge<br>drug delivery technologies, including sustained-release systems and advanced ocular implants, this revolutionary<br>approach aims to address the limitations of conventional eye drops and transform glaucoma care. In conclusion,<br>the integration of innovative latanoprost drug delivery systems holds great promise for revolutionizing glaucoma<br>care. These advancements offer the potential to significantly reduce the burden of vision loss associated with<br>glaucoma and improve the quality of life for affected individuals. Further research and clinical trials are essential<br>to validate the safety and efficacy of these new approaches and usher in a new era of glaucoma management.</p>2024-09-15T00:00:00+00:00Copyright (c) 2024 Shivani R. Makhijanihttp://asiapharmaceutics.info/index.php/ajp/article/view/5643Niosomes as Efficient Nanocarriers for Targeted Drug Delivery2024-10-24T06:29:16+00:00Anupriya Kapooranupriya321@gmail.com<p>The localization of pharmacological molecules to stick locations is made possible by target-specific drug delivery<br>systems with its bi-layer structure made of non-ionic surfactants, the noisome vesicular system can temporarily<br>increase a drug’s bioavailability in a specific location. Scientists who study drug delivery systems have been highly<br>concerned with the creation of vesicles as a means of enhancing medication delivery in recent years. Niosomes’<br>amphiphilic character enhances their ability to effectively encapsulate hydrophilic or lipophilic medications. It<br>is common practice to add additional ingredients, like cholesterol, to preserve the niosomes’ structural stiffness.<br>When comparing the great chemical stability and effectiveness of the replacement with niosomes, liposomes use<br>vesicles for medicinal and therapeutic applications, which have several advantages. They boost the therapeutic<br>efficiency of drug molecules by keeping the medicine from exiting circulation too quickly, shielding it from its<br>genetic environment, and lessening its effect on target cells. This research concentrated on current advancements<br>in the distribution of niosomal medications, potential advantages over other delivery systems, building techniques,<br>characterization techniques, and recent research that is noisy. The use of niosomes in nanotechnology has the<br>potential to yield highly targeted, non- infective, and non-cancer agents. Proniosomes and aspasomes are a few<br>examples of novel concepts that have been used to enhance niosomes’ drug delivery capabilities. Niosomes<br>are also beneficial as a living component of vaccines and for diagnostic tests. Therefore, further research and<br>development are required in these areas to produce the niosomal preparations that are now on the market.</p>2024-09-15T00:00:00+00:00Copyright (c) 2024 Anupriya Kapoor